BSE filing, NSE: KAMRON. Summary written from the filing by ALFA Finder's alert engine.
Adline Chem Lab Ltd: key numbers
- Share price
- ₹15.79
- Market cap
- ₹9.24 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.28 Cr
- P/E (TTM)
- -48.7×Sector 46.1×
- Promoter holding
- 25.85%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Adline Chem Lab Ltd
All →Adline Chem Lab Other Announcement
The company informed the exchange that the disclosure of related party transactions (Regulation 23(9)) is not applicable to it for the half-year ended September 30, 2026.
Adline Chem Lab Annual General Meeting
Adline Chem Lab Ltd held its 38th Annual General Meeting on September 28, 2026. The meeting covered the adoption of financial statements and routine director and auditor appointments.
Adline Chem Lab Annual General Meeting
Adline Chem Lab Limited has scheduled its 38th Annual General Meeting for September 28, 2026. The meeting will be held via video conferencing.
Adline Chem Lab Management Change
Adline Chem Lab Ltd announced the resignation of its statutory auditor, Jain Kedia & Sharma. The Board appointed V. V. Patel & Co. to fill the vacancy.
Adline Chem Lab Board Meeting Outcome
Adline Chem Lab Ltd announced its AGM date of September 28, 2026, and the appointment of Mrs. Anita Ganeshbhai Marvadi as an Independent Director.
Adline Chem Lab Q1 FY27 Results: Net Profit ₹0 Cr
Adline Chem Lab Ltd reported net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.